SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-333816
Filing Date
2021-11-18
Accepted
2021-11-18 16:11:12
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 6-K d211889d6k.htm 6-K 17023
2 EX-99.1 d211889dex991.htm EX-99.1 265758
3 EX-99.2 d211889dex992.htm EX-99.2 101128
4 EX-99.3 d211889dex993.htm EX-99.3 96849
  Complete submission text file 0001193125-21-333816.txt   2729150

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ncna-20210930.xml EX-101.INS 618334
6 XBRL TAXONOMY EXTENSION SCHEMA ncna-20210930.xsd EX-101.SCH 30921
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20210930_cal.xml EX-101.CAL 33203
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20210930_def.xml EX-101.DEF 69203
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20210930_lab.xml EX-101.LAB 200229
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20210930_pre.xml EX-101.PRE 157318
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 211424558
SIC: 2834 Pharmaceutical Preparations